Women suffering from the autoimmune disease multiple sclerosis temporarily get much better when pregnant. Researchers have now identified the beneficial changes naturally occurring in the immune system during pregnancy.
A new report from researchers at the George Washington University Milken Institute School of Public Health presents the most detailed evidence to date regarding the potential effects on mothers and children of Braidwood Management v Becerra, which challenges the constitutionality of the Affordable Care Act’s comprehensive free preventive benefit guarantee for nearly all privately insured people.
Mount Sinai Health System experts will lead key discussions on women’s health, new paths to treat and prevent brain disease, and closing the gap on health disparities at this year’s Aspen Ideas: Health and Aspen Ideas Festival.
In a global perspective, depression is the leading cause of ill health and disability. More than 264 million people are affected and at least 25 per cent of all women and 15 per cent of all men experience a depression that requires treatment at some point during their life.
A first-of-its-kind prognostic test approved by the FDA can now help doctors in the United States predict whether a woman will develop severe preeclampsia during pregnancy.
As more families consider bariatric surgery a viable option to treat their child’s obesity, it is important to stay up-to-date on the latest research on weight loss. You can find the latest research on bariatric surgery and other weight loss options in the Weight Loss channel on Newswise, where journalists can find story ideas on this trending topic.
Susan G. Komen is relieved to see the recommendation that all women get screened for breast cancer every other year starting at age 40. This is a meaningful step in the right direction but it is just a start.
For decades, people struggling with infertility had to add social stigma to problems. A Penn State Health doctor discusses the causes and treatments of infertility and how attitudes have shifted.
The Endocrine Society selected Dalal S. Ali, M.D., as the recipient of its 2023 C. Wayne Bardin, MD, International Travel Award for her outstanding ENDO abstract and research contributions related to bone disease, calcium and endocrine disorders in pregnancy.
The University of Chicago Medicine opened its first women’s health clinic in Chicago’s northern suburbs as the Hyde Park-based academic health system continues to expand its primary and specialty care offerings closer to patients’ homes.
An international research team from Tanzania and Japan created a smartphone app and conducted a pilot study of how the app might be used to improve midwives’ knowledge and skills in Tanzania. Their study focused on the app’s potential effects on the learning outcomes of midwives and birth preparedness of pregnant women in Tanzania.
University of Maryland Medical Center, located in the healthcare hub city of Baltimore, receives national recognition for its academic maternal care units.
MEDSIR announced today the results of the PALMIRA trial. This randomized phase 2 study evaluated the safety and efficacy of palbociclib maintenance in combination with second-line endocrine therapy in patients with hormone receptor-positive/HER2-negative (HR+/HER2-) advanced breast cancer who had showed a confirmed progressive disease on first-line palbociclib plus endocrine therapy-based treatment after having achieved clinical benefit to this regimen.
Researchers at the Beckman Institute for Advanced Science and Technology found that early exposure to an environmental chemical called polychlorinated biphenyls, or PCBs, made it more difficult for mice to recover from sound-related trauma sustained later in life.
An observational cohort study out of Roswell Park Comprehensive Cancer Center demonstrates that race and ethnicity affect a woman’s 21-gene recurrence score, a tool used to determine risk of recurrence and distant metastasis in patients with early-stage, hormone-receptor-positive breast cancer. Based on the expression of 21 cancer-related genes detected in pre-treatment tumor specimens, recurrence score is used routinely in clinical care to identify patients who might benefit from chemotherapy as part of their treatment plan. Scores range from 0-100, with a score of 26 or higher indicating greater risk of recurrence and poorer overall survival.
Women ages 45 years and older taking estrogen hormone therapy in pill form were more likely to develop high blood pressure than those using transdermal (topical, applied to the skin) or vaginal formulations, according to new research published today in Hypertension, a peer-reviewed American Heart Association journal.